Project Details
Projekt Print View

Reversing CRF-induced inhibition of KCa3.1 channels to treat acquired epilepsy

Subject Area Molecular and Cellular Neurology and Neuropathology
Clinical Neurology; Neurosurgery and Neuroradiology
Term from 2020 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 437921518
 
Final Report Year 2024

Final Report Abstract

Epilepsy is one of the most common neurological disorders world-wide. Chronic epilepsy is characterized by brain hyperexcitability and the emergence of spontaneous seizures. A major fraction of epilepsy patients still exhibits seizures despite treatment with multiple antiepileptic drugs, in particular in temporal lobe epilepsy (TLE). Furthermore, TLE is also associated with prominent cognitive comorbidities, ranging from memory deficits to mood disorders, for which there are currently no approved treatments available. Accordingly, there is great need for developing more effective drugs for both of these detrimental key symptoms of epilepsy. Our preliminary findings show that upregulation of the CRF-CRF1R-PKA receptor signaling pathway causes down-regulation of KCa3.1 channel activity in experimental TLE. Thus, a key usedependent mechanism inhibiting neuronal activity is lost. Importantly, we show that KCa3.1 channel activity can be recovered with CRF1 receptor antagonists, restoring neuronal excitability to a near normal level. Here we propose to further study this mechanism of brain hyperexcitability in TLE in order to establish its translational potential. We expect that pursuing these objectives will provide fundamental insights on the role of KCa3.1 downregulation by CRF1 receptors in TLE, as well as on the possible clinical usage of CRF1 receptor antagonists as antiepileptics and cognitive enhancers in this epileptic disorder.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung